✦ LIBER ✦

Safety and pharmacokinetics of the antisense oligonucleotide (ASO) LY2181308 as a single-agent or in combination with idarubicin and cytarabine in patients with refractory or relapsed acute myeloid leukemia (AML)

✍ Scribed by Harry P. Erba, Hamid Sayar, Mark Juckett, Michael Lahn, Valerie Andre, Sophie Callies, Shelly Schmidt, Sunil Kadam, John T. Brandt, Dirk Van Bockstaele, Michael Andreeff…show all 11hide

Book ID: 120966766
Publisher: Springer US
Year: 2013
Tongue: English
Weight: 425 KB
Volume: 31
Category: Article
ISSN: 0167-6997
DOI: 10.1007/s10637-013-9935-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase 2 randomized study of p53 antisens

Phase 2 randomized study of p53 antisense oligonucleotide (cenersen) plus idarubicin with or without cytarabine in refractory and relapsed acute myeloid leukemia

✍ Jorge Cortes; Hagop Kantarjian; Edward D. Ball; John DiPersio; Jonathan E. Kolit 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB

A phase I trial of a single high dose of

A phase I trial of a single high dose of idarubicin combined with high-dose cytarabine as induction therapy in relapsed or refractory adult patients with acute lymphoblastic leukemia

✍ Weiss, M A; Drullinsky, P; Maslak, P; Scheinberg, D; Golde, D W 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 42 KB

A Phase 2 study of bortezomib combined w

A Phase 2 study of bortezomib combined with either idarubicin/cytarabine or cytarabine/etoposide in children with relapsed, refractory or secondary acute myeloid leukemia: A report from the Children's Oncology Group

✍ Horton, Terzah M.; Perentesis, John P.; Gamis, Alan S.; Alonzo, Todd A.; Gerbing 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB

Absence of mutations in the deoxycytidin

Absence of mutations in the deoxycytidine kinase (dCK) gene in patients with relapsed and/or refractory acute myeloid leukemia (AML)

✍ van den Heuvel-Eibrink, M M; Wiemer, E A C; Kuijpers, M; Pieters, R; Sonneveld, 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 80 KB